CONFIDENTIAL — APPROVED FOR PUBLIC RELEASE · BUREAU FILE COPY RECORDS CURRENT AS OF 29 MAY 2026 · DISTRIBUTION: UNRESTRICTED
VendorInvestigate Independent Testing Bureau · Public Records Division
DOCKET YEAR 2026 · VOL. II
35,156 SAMPLES ON FILE
No fee · No favor
Compound Evidence File
#EC-2026-0366

1-Benzyl-4-piperidone CAS 3612-20-2

Filed under Raw Materials. The bureau holds 100 laboratory returns for this compound from 32 distinct subjects. Scores below are per-subject aggregates; open a subject row for the underlying evidence.

Cross-Index

Subjects Shipping This Compound

32 SUBJECTS
SubjectGradeSamplesMeanMinMaxFirst seenLast seen
HomopeptideCASE #VI-2026-0760A510.09.910.024 May 202624 May 2026
QYAOBIOCASE #VI-2026-0861A410.010.010.026 Jan 20269 Jun 2026
JEEP PeptidesCASE #VI-2026-0457A410.010.010.016 Feb 20263 Jun 2026
Hubei JianxiangCASE #VI-2026-0048A410.09.910.01 Jan 202612 Jul 2026
WuXi TIDESCASE #VI-2026-0335A410.09.910.022 Jan 202612 May 2026
PolyPeptide GroupCASE #VI-2026-0143A410.09.910.012 Feb 202621 May 2026
BachemCASE #VI-2026-0314A310.010.010.01 May 20265 Jul 2026
Shanghai Wibson BiotechnologyCASE #VI-2026-0379A310.09.910.023 Feb 20264 Jun 2026
Shanghai Sigma AudleyCASE #VI-2026-0505A310.09.910.04 Jan 202619 May 2026
GenScript PeptidesCASE #VI-2026-0860A310.09.910.027 Jun 202611 Jul 2026
Thermo Fisher ScientificCASE #VI-2026-0142A310.09.910.026 May 20266 Jul 2026
SinoPepCASE #VI-2026-0387A310.010.010.01 Mar 20266 Jul 2026
AsymchemCASE #VI-2026-0091A310.09.910.07 Apr 202619 Jul 2026
AmbioPharmCASE #VI-2026-0177A310.09.910.07 Jul 202621 Jul 2026
Mokemei BiotechnologyCASE #VI-2026-0540A210.010.010.08 Dec 20251 Mar 2026
Flourishglobal PeptideCASE #VI-2026-0630A210.010.010.016 Mar 20269 Jun 2026
Shanghai JinBei Chemical TechnologyCASE #VI-2026-0107X110.010.010.021 May 202521 May 2025
Tianjin Finder Chemical TFCCASE #VI-2026-0693A59.99.910.014 Nov 202516 Apr 2026
Shanghai ERP BiotechnologyCASE #VI-2026-0936A49.99.910.03 Nov 20252 Jul 2026
Kerui PeptidesCASE #VI-2026-0626A49.99.910.011 Nov 202513 Jun 2026
Sangon BioCASE #VI-2026-0671A39.99.910.05 Jun 202619 Jun 2026
Chinese Peptide CompanyCASE #VI-2026-0184A29.99.910.015 Jun 202617 Jun 2026
Hybio PharmaceuticalCASE #VI-2026-0065A29.99.910.05 May 202621 Jun 2026
Sigma-AldrichCASE #VI-2026-0829A29.99.99.93 Feb 202626 Jun 2026
Qingdao Sigma Chemical QSCCASE #VI-2026-0538A28.98.19.723 May 202623 May 2026
Shanghai Sigma Audley SSACASE #VI-2026-0486A28.68.09.224 May 202624 May 2026
Nantong Guangyuan Chemical GYCCASE #VI-2026-0284A38.58.19.023 May 202623 May 2026
Wuhan Wansheng Bio (WWB)CASE #VI-2026-0594A68.26.09.923 May 202623 May 2026
Glbiochem (Shanghai)CASE #VI-2026-0704A68.06.79.223 May 202623 May 2026
Hebei Rimao TechnologyCASE #VI-2026-0529X37.46.88.313 Feb 202524 May 2026
Nanjing Xiyuxun Technology XYXCASE #VI-2026-0433X16.26.26.228 Mar 202528 Mar 2025
Huayi BiotechnologyCASE #VI-2026-0243X14.34.34.32 Apr 20252 Apr 2025

Open any subject to view the batch-level evidence for 1-Benzyl-4-piperidone CAS 3612-20-2 alone.